SCHEMBL7804422

SCHEMBL7804422

O=C(O)CCOc1ccccc1N1CCN(C(=O)c2ccc(Br)cc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.56
NPSR1 Q6W5P4 3/20 0.55
USP2 O75604 1/20 0.55
HSD17B10 Q99714 1/20 0.55
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
POLB P06746 2/20 0.55
TSHR P16473 2/20 0.53
HCRTR1 O43613 1/20 0.52
DRD2 P14416 1/20 0.51
HTR2A P28223 1/20 0.51
LMNA P02545 2/20 0.50
PKM P14618 2/20 0.50
HTT P42858 2/20 0.50
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.47
REV1 Q9UBZ9 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817555 0.92 SMN1; SMN2 (0.61) SMN1; SMN2NPSR1USP2HSD17B10KMT2A
SCHEMBL7817574 0.84 LMNA (0.58) SMN1; SMN2NPSR1USP2HSD17B10KMT2A
SCHEMBL7811675 0.80 KMT2A (0.58) KMT2AMEN1LMNAHTTALDH1A1
SCHEMBL7811440 0.79 LMNA (0.57) SMN1; SMN2NPSR1USP2HSD17B10KMT2A
SCHEMBL7813964 0.79 CA12 (0.45) KMT2ADRD2LMNAALDH1A1HPGD
SCHEMBL7817803 0.79 MAPT (0.55) SMN1; SMN2NPSR1KMT2AMEN1DRD2
SCHEMBL7810089 0.79 MAPT (0.53) SMN1; SMN2NPSR1USP2KMT2AMEN1
SCHEMBL7813995 0.78 USP2 (0.60) NPSR1USP2HSD17B10KMT2AMEN1
SCHEMBL7810164 0.77 MEN1 (0.58) SMN1; SMN2NPSR1USP2HSD17B10KMT2A
SCHEMBL27298400 0.75 GAA (0.65) SMN1; SMN2NPSR1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed